Levomoramide
From Wikipedia, the free encyclopedia
Levomoramide
|
|
Systematic (IUPAC) name | |
(3S)-3-methyl-4-morpholin-4-yl-2,2-diphenyl-1-pyrrolidin-1-yl-butan-1-one | |
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C25H32N2O2 |
Mol. mass | 392.534 |
SMILES | & |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Levomoramide is the inactive isomer of the opioid analgesic dextromoramide, invented by the chemist Paul Janssen in 1956. Unlike dextromoramide, which is a potent analgesic with high abuse potential, levomoramide is virtually without activity.[1][2]
"Resolution reveals that the analgetic activity in this case resides almost entirely in the (+) isomer."[3]
"In the α-CH3 series, one of the optical isomers of each enantiomorphic pair is about twice as active as the racemic mixture; the other isomer is devoid of significant analgesic activity."[4]
However despite being inactive, levomoramide is controlled internationally as a Schedule I drug.
[edit] References
- ^ Janssen PA. Journal of the American Chemical Society. 1956;78:3862.
- ^ Janssen PA, Jagenau AM. Journal of Pharmacy and Pharmacology 1957;9:381.
- ^ Daniel Lednicer. Central Analgetics. (1982), p194. ISBN 0-471-08314-3
- ^ Paul A J Janssen. Synthetic Analgesics Part 1: Diphenylpropylamines. Pergamon Press 1960. p143.